Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials
Authors: Iribarren C; Rothman KJ; Bradley MS; Carrigan G; Eisner MD; Chen H
J Allergy Clin Immunol. 2017 05;139(5):1678-1680. Epub 2017-01-17.